Related Experiment Video
Updated: Dec 8, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Why are pharmacy acquisition costs and consumer prescription drug price indices apparently diverging?
Carolyn Wolff1, Randall Lutter1
1U.S. Food and Drug Administration, Office of the Commissioner, Silver Spring, Maryland, USA.
Abstract:
Pharmacy acquisition costs for prescription (Rx ) drugs have been trending below levels implied by the Bureau of Labor Statistics' (BLS) Consumer Price Index for Rx drugs, with the divergence higher when generic approvals are high. Dropping the first 6 months of generic sales from price indices calculated from pharmacy acquisition costs eliminates most of the difference between such indices and BLS indices.
More Related Videos
Related Concept Videos
Pharmaceutical Equivalents
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Drug Dissolution: Requirements and Profile Comparison
Bioequivalence: Overview

